Retinoic Acid Promotes Interleukin-4 Plasmid-Dimethylsulfoxide Topical Transdermal Delivery for Treatment of Psoriasis

BACKGROUND: Psoriasis is an autoimmune disease that is caused by a shift in the Th1/Th2 balance toward Th1-dominant immunity. It has been established as an effective treatment to counteract psoriasis by subcutaneous injection of recombinant interleukin (IL)-4, and IL-4 gene therapy by topical transd...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhong-Wen, Zhang, Yin-Bing, Chen, Xaing-Jun, Liu, Xiao, Wang, Zhen, Zhou, Xi-Kun, Qiu, Ji, Zhang, Nan-Nan, Teng, Xiu, Mao, Yong-Qiu, Liu, Chang-Yong, Wei, Yu-Quan, Li, Jiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377399/
https://www.ncbi.nlm.nih.gov/pubmed/25834349
http://dx.doi.org/10.5021/ad.2015.27.2.121

Ejemplares similares

Ejemplares similares